coronavirus
overview
coronavirus
cov
divers
group
virus
capabl
infect
human
wide
rang
anim
cov
affect
multipl
system
caus
respiratori
gastrointestin
hepat
neurolog
ill
rang
mild
sick
death
cov
classifi
multipl
genera
includ
alpha
beta
gamma
delta
coronavirus
note
cov
seem
abl
adapt
new
host
chang
environ
may
relat
cov
abil
mutat
recombin
perhap
contribut
novel
virus
vari
human
pathogen
coronavirus
order
nidoviral
famili
coronavirida
genu
coronaviru
larg
envelop
singl
strand
positivesens
rna
virus
capabl
infect
varieti
anim
includ
bat
mice
bird
dog
pig
cattl
human
identifi
mani
decad
ago
coronaviru
figur
latin
corona
translat
crown
halo
repres
appear
cov
virion
view
electron
microscop
viru
appear
creat
viral
spike
peplom
popul
surfac
determin
host
tropism
figur
typic
cov
consid
highli
speciesspecif
immunocompet
host
infect
elicit
immun
respons
neutral
antibodi
cellmedi
immun
respons
attempt
kill
infect
cell
coronavirus
member
coronavirida
famili
identifi
group
base
upon
serolog
crossreact
genom
sequenc
homolog
host
rang
divers
includ
canin
felin
swine
mice
camel
bat
bird
human
across
four
genera
coronavirus
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
high
frequenc
recombin
rate
mutat
believ
allow
cov
adapt
new
host
environ
sar
cov
good
illustr
studi
reveal
origin
animalsbat
natur
reservoir
palm
civet
intermedi
host
underscor
infect
risk
human
anim
interactionsoccup
adventur
travel
well
environment
incurs
chang
habit
expect
climat
chang
pose
signific
risk
human
well
anim
health
anim
pathogen
coronavirus
lead
highli
virul
respiratori
enter
neurolog
diseas
addit
hepat
result
epizoot
respiratori
diseas
andor
gastroenter
human
viru
rang
diseas
broad
cold
like
sever
multisystem
involv
cov
infect
associ
short
incub
period
day
found
sar
sever
coronavirus
capabl
caus
fatal
system
diseas
anim
includ
felin
infecti
periton
viru
fipv
swine
hemagglutin
encephalomyel
viru
hev
strain
avian
infecti
bronchiti
viru
ibv
mous
hepat
viru
mhv
particular
cov
replic
liver
lung
kidney
gut
spleen
brain
spinal
cord
retina
well
tissu
accord
cdc
first
case
sar
cov
report
asia
earli
investig
note
novemb
first
case
atyp
pneumonia
emerg
china
guangdong
provinc
ultim
caus
agent
determin
newli
discov
coronaviru
epidem
similarli
sever
atyp
pneumonia
emerg
hong
kong
guangdong
toronto
ontario
follow
timelin
initi
event
transpir
refer
sar
cov
februari
china
report
world
health
organ
case
atyp
pneumonia
unknown
etiolog
identifi
guangdong
provinc
sinc
novemb
five
peopl
die
februari
physician
guangdong
provinc
ill
atyp
pneumonia
travel
hong
kong
stay
overnight
hotel
etiolog
caus
ill
identifi
sever
acut
respiratori
syndrom
coronaviru
sar
cov
like
transmit
least
addit
person
transmissionsinfect
subsequ
initi
outbreak
hong
kong
singapor
viet
nam
canada
symptom
characterist
aggress
atyp
pneumonia
includ
onset
ill
associ
high
fever
temperatur
greater
headacheoften
sever
overal
feel
discomfort
bodi
ach
often
sever
person
may
respiratori
symptom
outset
approxim
percent
experienc
diarrhea
day
sar
patient
may
develop
dri
cough
patient
develop
pneumonia
given
prior
outbreak
highli
pathogen
avian
influenza
region
china
first
consid
emerg
flu
viru
pathogen
includ
member
paramyxovirida
famili
human
metapneumoviru
hmpv
consid
caus
new
clinic
ill
becam
known
sever
acut
respiratori
syndrom
sar
intern
collabor
among
multipl
research
facil
previous
unknown
pathogen
ultim
determin
caus
sar
new
coronaviru
sar
cov
while
sar
cov
signific
pathogen
capabl
caus
profound
ill
even
death
histor
coronavirus
one
caus
common
cold
known
endem
human
betacoronavirus
coronavirus
affect
human
hcov
histor
associ
mild
ill
found
group
group
widespread
caus
mild
respiratori
ill
although
occasion
cov
caus
seriou
infect
lower
respiratori
tract
children
adult
includ
necrot
enterocol
newborn
earli
research
sar
cov
genom
sequenc
demonstr
new
cov
belong
known
group
coronavirus
previous
describ
human
coronavirus
fact
appear
sar
cov
somewhat
relat
hcov
sarscov
genom
appear
equidist
known
coronavirus
moreov
sar
cov
closest
rel
appear
murin
bovin
porcin
human
coronavirus
group
avian
coronaviru
ibv
group
research
sar
cov
suggest
new
viru
repres
fourth
group
lineag
coronaviru
group
genom
sequenc
analysi
seem
support
hypothesi
sarscov
anim
viru
normal
host
still
unknown
develop
abil
product
infect
human
abil
cross
speci
barrier
genom
show
sarscov
neither
mutant
known
coronaviru
recombin
known
coronavirus
viru
pass
human
be
sarscov
maintain
genotyp
adapt
human
host
test
allow
genet
analysi
distinguish
differ
strain
sarscov
allow
epidemiolog
studi
surprisingli
also
econom
well
health
implic
coronavirus
caus
import
diseas
domest
anim
well
human
popul
toronto
aftermath
sar
outbreak
saw
signific
albeit
temporari
declin
tourism
busi
relat
visit
well
lost
confer
trade
show
relat
commerc
recogn
import
animalhuman
pathogen
crossov
opportun
reduc
spread
contagion
identifi
potenti
risk
critic
prevent
least
reduc
likelihood
sar
mer
influenza
outbreak
avian
influenza
outbreak
swine
flu
outbreak
sar
cov
figur
detect
extract
lung
kidney
tissu
viru
isol
pcr
bronchoalveolar
lavag
specimen
viru
isol
electron
microscopi
pcr
sputum
upper
respiratori
tract
swab
aspir
wash
specimen
pcr
sarsassoci
coronaviru
rna
detect
nasopharyng
aspir
rtpcr
initi
present
mean
day
onset
ill
day
stool
sampl
viral
rna
detect
patient
two
week
onset
ill
urin
sampl
posit
viral
rna
viral
rna
also
detect
extrem
low
concentr
plasma
acut
phase
fece
late
convalesc
phase
suggest
viru
may
shed
fece
prolong
period
time
timelin
event
note
cdc
conclud
toward
end
remov
travel
warn
china
ontario
end
accord
cdc
report
data
report
sar
infect
countri
region
reveal
person
probabl
sar
result
deathswith
estim
case
fatal
rate
higher
elderli
infirm
patient
unit
state
eight
sar
infect
document
laboratori
test
addit
probabl
sar
infect
report
cdc
issu
notic
embargo
civet
sarslik
viru
isol
civet
captur
area
china
sar
outbreak
origin
cdc
also
ban
import
civet
civet
mammal
catlik
bodi
long
leg
long
tail
mask
face
resembl
raccoon
weasel
sar
cov
detect
anim
handler
civet
ban
civet
current
still
effect
nation
select
agent
registri
program
declar
sarscoronaviru
select
agent
select
agent
bacterium
viru
toxin
potenti
pose
sever
threat
public
health
safeti
spite
signific
effort
develop
countermeasur
coronavirus
three
yet
licens
therapeut
shown
consist
effect
mer
cov
sar
cov
intens
careprovid
ventil
circulatori
organ
system
support
preserv
renal
hepat
neurolog
function
well
prevent
secondari
infect
critic
sar
cov
pandem
immun
base
therapi
tri
equivoc
result
ribavirin
interferon
combin
show
clinic
improv
non
human
primat
studi
unlik
actual
clinic
experi
mer
sar
ill
let
alon
treatment
rare
initi
rapidli
infect
trial
provid
intervent
soon
viral
challeng
sar
cov
epidem
variou
combin
therapi
trial
scale
control
approach
conduct
make
recommend
current
antivir
without
interferon
combin
therapi
concern
question
ribavirin
potent
nucleosid
analogu
use
vari
degre
success
rna
virus
potenti
advers
side
effect
includ
hemolyt
anemia
metabol
derang
interferon
also
elicit
advers
effect
although
demonstr
valu
viral
infect
corticosteroid
tri
sar
cov
infectionthey
result
increas
viral
load
admiss
intens
care
unit
mortal
sar
cov
convalesc
plasma
hyperimmun
globulin
shown
rel
safe
possibl
effect
reduc
mortal
convalesc
plasma
administ
within
day
ill
decreas
mortal
sar
cov
patient
accord
one
studi
found
time
critic
issueadministr
given
within
week
period
challeng
cours
identifi
case
contact
rapidli
immedi
util
therapi
chanc
optim
effect
donor
suppli
technic
capac
region
sar
mer
emerg
threat
like
occur
safeti
end
product
challeng
limit
potenti
therapeut
option
monoclon
antibodi
mab
offer
promis
demonstr
efficaci
treatment
cancer
autoimmun
diseas
well
respiratori
syncyti
viru
rsv
trial
ongo
determin
use
mab
ebola
viru
diseas
hiv
primari
secondari
prevent
unfortun
cost
well
research
develop
timelin
longer
polyclon
antibodi
prepar
nevertheless
spite
rigor
test
regulatori
cost
issu
associ
mab
potenti
therapi
mer
potenti
deadli
diseas
continu
drive
research
area
antivir
research
adenin
analogu
disrupt
viral
rna
replic
develop
well
nucleosid
analogu
potenti
work
filovirus
coronavirus
rna
virus
ideal
antivir
cover
broad
rang
coronavirus
develop
base
upon
genet
sequenc
virus
life
cycl
develop
antimicrobi
intervent
still
remain
futur
note
extens
research
also
conduct
toward
develop
vaccin
toward
end
unlik
vaccin
direct
toward
pathogen
research
focus
viral
structur
replic
mechan
figur
tabl
surprisingli
pathogen
dengu
remain
unknown
protect
immun
cross
protect
varieti
strain
technic
difficulti
varieti
challeng
overcom
develop
effect
vaccin
sar
coronavirus
exampl
develop
live
sar
cov
vaccin
necessari
address
variou
coronaviru
strain
recombin
potenti
attenu
part
genom
replac
nonattenu
compon
genom
result
pathogen
viru
one
approach
consid
use
revers
genet
may
elimin
risk
recombin
coronaviru
strain
suddenli
sar
cov
emerg
seemingli
gone
quiescent
howev
anoth
signific
previous
unknown
describ
coronaviru
respiratori
diseas
emerg
next
section
newest
member
cov
discov
caus
human
ill
discuss
middl
east
respiratori
syndrom
coronaviru
merscov
mer
part
beta
group
coronavirus
